Tag Archives: fda safety warning

According to news sources , the drug Multaq is getting a new safety warning after a study found increased risks of heart attack, stroke and death associated with the drug with a subset of patients that took part in the study. The heart rhythm drug controls the heart’s chambers by allowing them to pump in sync for patients with atrial fibrillation. The new warning would allow the drug to remain on the market but would stress to doctors and patients that it be used only for treatment of the short-term variant of the condition. Continue reading →